Skip to content

Magnus Medical

5 viewers · 30d

Total raised

$89.3M

3 filings since 2025 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $49.0M
ROUNDS
3
INVESTORS
10
FOUNDED
2020
HQ
Burlingame, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
5

AI overview

Updated

Magnus Medical, Inc. is a pioneering medical device company that specializes in developing advanced neuromodulation technology aimed at addressing major depressive disorder (MDD). With a focus on innovative treatments for those suffering from treatment-resistant depression, Magnus Medical is at the forefront of mental health solutions, utilizing cutting-edge neuroscience to improve patient outcomes.

What sets it apart

What sets Magnus Medical apart is its SAINT neuromodulation system, which combines personalized brain mapping with high-dose stimulation to provide rapid and effective treatment options for patients who have not responded to traditional therapies.

Funding history

3 rounds
EquityMay 1, 2025
Form D
+$23.7M$89.3M total
EquityMay 1, 2025
Form D/A
+$49.0M$89.3M total
EquityFeb 7, 2025
Form D
+$40.3M$40.3M total

Products

1 tracked

SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy)

Medical Device

The SAINT system is an advanced neuromodulation device that employs transcranial magnetic stimulation (TMS) to deliver individualized and accelerated treatment for major depressive disorder. This innovative approach focuses on identifying precise brain targets, ensuring that treatment is tailored to the unique physiology of each patient.

  • Utilizes structural and functional MRI scans for personalized brain target identification
  • Delivers high-dose intermittent theta burst stimulation (iTBS)
  • Offers a rapid and efficient 5-day treatment protocol

Links

WebsiteSEC EDGAR filings